COPD Drugs Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 COPD Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global COPD Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global COPD Drugs Overall Market Size
2.1 Global COPD Drugs Market Size: 2021 VS 2027
2.2 Global COPD Drugs Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top COPD Drugs Players in Global Market
3.2 Top Global COPD Drugs Companies Ranked by Revenue
3.3 Global COPD Drugs Revenue by Companies
3.4 Top 3 and Top 5 COPD Drugs Companies in Global Market, by Revenue in 2020
3.5 Global Companies COPD Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 COPD Drugs Players in Global Market
3.6.1 List of Global Tier 1 COPD Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 COPD Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global COPD Drugs Market Size Markets, 2021 & 2027
4.1.2 Bronchodilators
4.1.3 PDE-4 Inhibitors
4.1.4 Steroids
4.1.5 Combination Therapies
4.1.6 Others
4.2 By Type - Global COPD Drugs Revenue & Forecasts
4.2.1 By Type - Global COPD Drugs Revenue, 2016-2021
4.2.2 By Type - Global COPD Drugs Revenue, 2022-2027
4.2.3 By Type - Global COPD Drugs Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global COPD Drugs Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global COPD Drugs Revenue & Forecasts
5.2.1 By Application - Global COPD Drugs Revenue, 2016-2021
5.2.2 By Application - Global COPD Drugs Revenue, 2022-2027
5.2.3 By Application - Global COPD Drugs Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global COPD Drugs Market Size, 2021 & 2027
6.2 By Region - Global COPD Drugs Revenue & Forecasts
6.2.1 By Region - Global COPD Drugs Revenue, 2016-2021
6.2.2 By Region - Global COPD Drugs Revenue, 2022-2027
6.2.3 By Region - Global COPD Drugs Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America COPD Drugs Revenue, 2016-2027
6.3.2 US COPD Drugs Market Size, 2016-2027
6.3.3 Canada COPD Drugs Market Size, 2016-2027
6.3.4 Mexico COPD Drugs Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe COPD Drugs Revenue, 2016-2027
6.4.2 Germany COPD Drugs Market Size, 2016-2027
6.4.3 France COPD Drugs Market Size, 2016-2027
6.4.4 U.K. COPD Drugs Market Size, 2016-2027
6.4.5 Italy COPD Drugs Market Size, 2016-2027
6.4.6 Russia COPD Drugs Market Size, 2016-2027
6.4.7 Nordic Countries COPD Drugs Market Size, 2016-2027
6.4.8 Benelux COPD Drugs Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia COPD Drugs Revenue, 2016-2027
6.5.2 China COPD Drugs Market Size, 2016-2027
6.5.3 Japan COPD Drugs Market Size, 2016-2027
6.5.4 South Korea COPD Drugs Market Size, 2016-2027
6.5.5 Southeast Asia COPD Drugs Market Size, 2016-2027
6.5.6 India COPD Drugs Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America COPD Drugs Revenue, 2016-2027
6.6.2 Brazil COPD Drugs Market Size, 2016-2027
6.6.3 Argentina COPD Drugs Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa COPD Drugs Revenue, 2016-2027
6.7.2 Turkey COPD Drugs Market Size, 2016-2027
6.7.3 Israel COPD Drugs Market Size, 2016-2027
6.7.4 Saudi Arabia COPD Drugs Market Size, 2016-2027
6.7.5 UAE COPD Drugs Market Size, 2016-2027
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer COPD Drugs Major Product Offerings
7.1.4 Pfizer COPD Drugs Revenue in Global (2016-2021)
7.1.5 Pfizer Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis COPD Drugs Major Product Offerings
7.2.4 Novartis COPD Drugs Revenue in Global (2016-2021)
7.2.5 Novartis Key News
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Corporate Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline COPD Drugs Major Product Offerings
7.3.4 GlaxoSmithKline COPD Drugs Revenue in Global (2016-2021)
7.3.5 GlaxoSmithKline Key News
7.4 Merck
7.4.1 Merck Corporate Summary
7.4.2 Merck Business Overview
7.4.3 Merck COPD Drugs Major Product Offerings
7.4.4 Merck COPD Drugs Revenue in Global (2016-2021)
7.4.5 Merck Key News
7.5 Abbott Laboratories
7.5.1 Abbott Laboratories Corporate Summary
7.5.2 Abbott Laboratories Business Overview
7.5.3 Abbott Laboratories COPD Drugs Major Product Offerings
7.5.4 Abbott Laboratories COPD Drugs Revenue in Global (2016-2021)
7.5.5 Abbott Laboratories Key News
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Corporate Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim COPD Drugs Major Product Offerings
7.6.4 Boehringer Ingelheim COPD Drugs Revenue in Global (2016-2021)
7.6.5 Boehringer Ingelheim Key News
7.7 AstraZeneca
7.7.1 AstraZeneca Corporate Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca COPD Drugs Major Product Offerings
7.4.4 AstraZeneca COPD Drugs Revenue in Global (2016-2021)
7.7.5 AstraZeneca Key News
7.8 Roche Holding AG
7.8.1 Roche Holding AG Corporate Summary
7.8.2 Roche Holding AG Business Overview
7.8.3 Roche Holding AG COPD Drugs Major Product Offerings
7.8.4 Roche Holding AG COPD Drugs Revenue in Global (2016-2021)
7.8.5 Roche Holding AG Key News
7.9 Teva Pharmaceutical Industries
7.9.1 Teva Pharmaceutical Industries Corporate Summary
7.9.2 Teva Pharmaceutical Industries Business Overview
7.9.3 Teva Pharmaceutical Industries COPD Drugs Major Product Offerings
7.9.4 Teva Pharmaceutical Industries COPD Drugs Revenue in Global (2016-2021)
7.9.5 Teva Pharmaceutical Industries Key News
7.10 Vectura Group
7.10.1 Vectura Group Corporate Summary
7.10.2 Vectura Group Business Overview
7.10.3 Vectura Group COPD Drugs Major Product Offerings
7.10.4 Vectura Group COPD Drugs Revenue in Global (2016-2021)
7.10.5 Vectura Group Key News
7.11 Mylan NV
7.11.1 Mylan NV Corporate Summary
7.11.2 Mylan NV Business Overview
7.11.3 Mylan NV COPD Drugs Major Product Offerings
7.11.4 Mylan NV COPD Drugs Revenue in Global (2016-2021)
7.11.5 Mylan NV Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. COPD Drugs Market Opportunities & Trends in Global Market
Table 2. COPD Drugs Market Drivers in Global Market
Table 3. COPD Drugs Market Restraints in Global Market
Table 4. Key Players of COPD Drugs in Global Market
Table 5. Top COPD Drugs Players in Global Market, Ranking by Revenue (2019)
Table 6. Global COPD Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global COPD Drugs Revenue Share by Companies, 2016-2021
Table 8. Global Companies COPD Drugs Product Type
Table 9. List of Global Tier 1 COPD Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 COPD Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global COPD Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - COPD Drugs Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - COPD Drugs Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global COPD Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - COPD Drugs Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - COPD Drugs Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global COPD Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global COPD Drugs Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global COPD Drugs Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America COPD Drugs Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America COPD Drugs Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe COPD Drugs Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe COPD Drugs Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia COPD Drugs Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia COPD Drugs Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America COPD Drugs Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America COPD Drugs Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa COPD Drugs Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa COPD Drugs Revenue, (US$, Mn), 2022-2027
Table 30. Pfizer Corporate Summary
Table 31. Pfizer COPD Drugs Product Offerings
Table 32. Pfizer COPD Drugs Revenue (US$, Mn), (2016-2021)
Table 33. Novartis Corporate Summary
Table 34. Novartis COPD Drugs Product Offerings
Table 35. Novartis COPD Drugs Revenue (US$, Mn), (2016-2021)
Table 36. GlaxoSmithKline Corporate Summary
Table 37. GlaxoSmithKline COPD Drugs Product Offerings
Table 38. GlaxoSmithKline COPD Drugs Revenue (US$, Mn), (2016-2021)
Table 39. Merck Corporate Summary
Table 40. Merck COPD Drugs Product Offerings
Table 41. Merck COPD Drugs Revenue (US$, Mn), (2016-2021)
Table 42. Abbott Laboratories Corporate Summary
Table 43. Abbott Laboratories COPD Drugs Product Offerings
Table 44. Abbott Laboratories COPD Drugs Revenue (US$, Mn), (2016-2021)
Table 45. Boehringer Ingelheim Corporate Summary
Table 46. Boehringer Ingelheim COPD Drugs Product Offerings
Table 47. Boehringer Ingelheim COPD Drugs Revenue (US$, Mn), (2016-2021)
Table 48. AstraZeneca Corporate Summary
Table 49. AstraZeneca COPD Drugs Product Offerings
Table 50. AstraZeneca COPD Drugs Revenue (US$, Mn), (2016-2021)
Table 51. Roche Holding AG Corporate Summary
Table 52. Roche Holding AG COPD Drugs Product Offerings
Table 53. Roche Holding AG COPD Drugs Revenue (US$, Mn), (2016-2021)
Table 54. Teva Pharmaceutical Industries Corporate Summary
Table 55. Teva Pharmaceutical Industries COPD Drugs Product Offerings
Table 56. Teva Pharmaceutical Industries COPD Drugs Revenue (US$, Mn), (2016-2021)
Table 57. Vectura Group Corporate Summary
Table 58. Vectura Group COPD Drugs Product Offerings
Table 59. Vectura Group COPD Drugs Revenue (US$, Mn), (2016-2021)
Table 60. Mylan NV Corporate Summary
Table 61. Mylan NV COPD Drugs Product Offerings
Table 62. Mylan NV COPD Drugs Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. COPD Drugs Segment by Type
Figure 2. COPD Drugs Segment by Application
Figure 3. Global COPD Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global COPD Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global COPD Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by COPD Drugs Revenue in 2020
Figure 8. By Type - Global COPD Drugs Revenue Market Share, 2016-2027
Figure 9. By Application - Global COPD Drugs Revenue Market Share, 2016-2027
Figure 10. By Region - Global COPD Drugs Revenue Market Share, 2016-2027
Figure 11. By Country - North America COPD Drugs Revenue Market Share, 2016-2027
Figure 12. US COPD Drugs Revenue, (US$, Mn), 2016-2027
Figure 13. Canada COPD Drugs Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico COPD Drugs Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe COPD Drugs Revenue Market Share, 2016-2027
Figure 16. Germany COPD Drugs Revenue, (US$, Mn), 2016-2027
Figure 17. France COPD Drugs Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. COPD Drugs Revenue, (US$, Mn), 2016-2027
Figure 19. Italy COPD Drugs Revenue, (US$, Mn), 2016-2027
Figure 20. Russia COPD Drugs Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries COPD Drugs Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux COPD Drugs Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia COPD Drugs Revenue Market Share, 2016-2027
Figure 24. China COPD Drugs Revenue, (US$, Mn), 2016-2027
Figure 25. Japan COPD Drugs Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea COPD Drugs Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia COPD Drugs Revenue, (US$, Mn), 2016-2027
Figure 28. India COPD Drugs Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America COPD Drugs Revenue Market Share, 2016-2027
Figure 30. Brazil COPD Drugs Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina COPD Drugs Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa COPD Drugs Revenue Market Share, 2016-2027
Figure 33. Turkey COPD Drugs Revenue, (US$, Mn), 2016-2027
Figure 34. Israel COPD Drugs Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia COPD Drugs Revenue, (US$, Mn), 2016-2027
Figure 36. UAE COPD Drugs Revenue, (US$, Mn), 2016-2027
Figure 37. Pfizer COPD Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Novartis COPD Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. GlaxoSmithKline COPD Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Merck COPD Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Abbott Laboratories COPD Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Boehringer Ingelheim COPD Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. AstraZeneca COPD Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Roche Holding AG COPD Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Teva Pharmaceutical Industries COPD Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Vectura Group COPD Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Mylan NV COPD Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Pfizer
Novartis
GlaxoSmithKline
Merck
Abbott Laboratories
Boehringer Ingelheim
AstraZeneca
Roche Holding AG
Teva Pharmaceutical Industries
Vectura Group
Mylan NV